Opinion|Videos|July 8, 2024
Optimizing Management of Atopic Dermatitis and Alopecia Areata: From First-Line to Second-Line Treatments and Safety Protocols
Author(s)Robert Bruce Posnick, MD
Robert Bruce Posnick, MD, examines a case of a 55-year-old female patient with a 50-year history of atopic dermatitis, comorbid asthma, and severe alopecia areata, presenting with recurrent patches throughout her body, predominantly affecting her face, hands, trunk, arms, legs, and eyelids.
Advertisement
- What is your impression of this case? What challenges does this case present with, if any?
- What co-morbidities do you typically see with Atopic Dermatitis?
- Given her history, would you treat systemically? If so, oral JAK or injectable biologic?
- Would you consider a topical JAK, ie ruxolitinib? If so, any concern using topical JAK in combo with systemic therapy, if so which ones?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5
